Semaglutide: The Weight-Loss Drug That Protects the Heart
In a trial of 17,604 people with cardiovascular disease and excess weight, semaglutide cut the combined risk of cardiovascular death, heart attack or stroke by 20%. None had diabetes. How did an appetite drug get here?
